Reply to “Pityriasis rosea during COVID-19 and its pathogenesis”

Reply to “Pityriasis rosea during COVID-19 and its pathogenesis”

Bibliographic Details
Main Authors:	Dillon Nussbaum, BS, Chapman Wei, MD, Haig Pakhchanian, BS, Rahul Raiker, BS, Ivan Z. Liu, BS, Adam Friedman, MD
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	JAAD International
Subjects:	covid-19 general dermatology herpesviridae pandemic pityriasis rosea viral exanthem
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666328722001262

Similar Items

Pityriasis rosea during COVID-19 and its pathogenesis
by: Francesco Drago, MD, et al.
Published: (2022-12-01)

Dupilumab-induced pityriasis rosea
by: Morgan Zabel, BS, et al.
Published: (2023-03-01)

Giant pityriasis rosea
by: Zawar Vijay
Published: (2010-01-01)

Doxycycline In Pityriasis Rosea: Placebo- Controlled Clinical Trial
by: Ghassaq Al-Timimi, et al.
Published: (2007-04-01)

What’s old is new: Valacyclovir for the treatment of pityriasis rosea, a retrospective case series
by: Gina M. Ashforth, MD, et al.
Published: (2023-07-01)

Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review
by: Potestio L, et al.
Published: (2024-01-01)

Prevalence of pityriasis rosea in the United States: A cross-sectional study using the All of Us database
by: Tejas P. Joshi, BS, et al.
Published: (2022-09-01)

Dupilumab-induced pityriasis rosea in a 28-year-old male with atopic dermatitis
by: Faraz Yousefian, DO, et al.
Published: (2024-03-01)

Multiple recurrences in Pityriasis rosea - A case report with review of the literature
by: Senthilkumar Sankararaman, et al.
Published: (2014-01-01)

Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine
by: Olivia G. Cohen, et al.
Published: (2021-11-01)

Pityriasis rosea with erythema multiforme - like lesions: An observational analysis
by: Vineet Relhan, et al.
Published: (2013-01-01)

Pityriasis Rosea and Pityriasis Rosea-like Eruption Following COVID-19 Vaccinations: Case Series from Oman
by: Iman Al Hatmi, et al.
Published: (2023-11-01)

Domperidone‐induced pityriasis rosea‐like drug eruption
by: Sarra Saad, et al.
Published: (2022-04-01)

Vaccine-induced pityriasis rosea and pityriasis rosea-like Eruptions: A review of literature and a case report of COVID-19 vaccine-induced pityriasis rosea
by: Eman Almukhadeb, et al.
Published: (2022-01-01)

An unusual variant: Photo-distributed pityriasis rosea
by: Defne Başkurt, et al.
Published: (2023-12-01)

Narrowband UVB phototherapy in pityriasis rosea
by: Vijayeeta Jairath, et al.
Published: (2015-01-01)

A Case of Persistent Pityriasis Rosea Successfully Treated by a Short Course of Therapy with Abrocitinib
by: Wu H, et al.
Published: (2024-04-01)

Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature
by: Stefano Veraldi, et al.
Published: (2022-07-01)

A case of pityriasis rosea of vidal accompanied by neurofibromatosis type 1
by: Ahu Yorulmaz, et al.
Published: (2015-07-01)

Clinical and pathological features of 5 cases of children pigmento-genes pityriasis rosea
by: Ting ZHANG, et al.
Published: (2022-12-01)

Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea
by: Sidharth Sonthalia, et al.
Published: (2018-08-01)

The efficacy of oral acyclovir during early course of pityriasis rosea: a systematic review and meta-analysis
by: Hua-Ching Chang, et al.
Published: (2019-04-01)

Recurrent pityriasis rosea: A case report
by: Ang Li, et al.
Published: (2018-04-01)

Line-field confocal optical coherence tomography assessment of pityriasis rosea
by: Gaurav N. Pathak, PharmD, et al.
Published: (2023-09-01)

Pityriasis rosea during the COVID-19 pandemic: Further support for a viral etiology
by: Harrison Zhu, BSA, et al.
Published: (2022-12-01)

Pityriasis Rosea Associated with Pegylated Interferon Alfa and Ribavirin Treatment in a Patient with Chronic Hepatitis C
by: Rahmet Güner, et al.
Published: (2013-06-01)

Drug-induced pityriasis lichenoides from infliximab in a patient with juvenile idiopathic arthritis
by: Nicole Boswell, BS, et al.
Published: (2022-05-01)

Pityriasis rosea in 12-months-old infant
by: Piotr Brzezinski, et al.
Published: (2012-04-01)

Viral exanthem in a healthy adult with rotavirus gastroenteritis
by: Takaaki Kobayashi, et al.
Published: (2023-01-01)

Pityriasis Rosea in a Pregnancy
by: Abdullah Karaer, et al.
Published: (2012-08-01)

Rethinking pityriasis rubra pilaris as a paraneoplastic syndrome: Two cases of pityriasis rubra pilaris with concomitant underlying malignancy
by: Anna E. Davis, BS, et al.
Published: (2023-02-01)

Refractory pityriasis rubra pilaris treated with upadacitinib
by: Eingun James Song, MD, et al.
Published: (2023-05-01)

Pityriasis rubra pilaris potentially triggered by messenger RNA–1273 COVID vaccine
by: Etsubdenk M. Ajebo, MD, et al.
Published: (2022-05-01)

A case of paraneoplastic pityriasis rubra pilaris
by: Nina Mehta, BS, et al.
Published: (2023-09-01)

Hypopigmented pityriasis lichenoides: A new clinicopathological type
by: Ayman M Mahran, et al.
Published: (2023-01-01)

Pityriasis lichenoides chronica induced by COVID-19 messenger RNA vaccination
by: Abdullah M. Al Muqrin, MD, et al.
Published: (2022-09-01)

Acute lichenoid and varioliform pityriasis in a pediatric patient
by: Eduardo Marín-Hernández, et al.
Published: (2023-04-01)

Pityriasis rubra pilaris following COVID-19 vaccination successfully treated with ixekizumab
by: Patricia Zhao, BS, et al.
Published: (2023-05-01)

Juvenil Pityriasis Rubra Pilaris: A Case Report
by: M. Emin YANIK et al., et al.
Published: (2010-05-01)

Tomato flu in children in India: What evidence do we have so far?
by: Parimala Mohanty, et al.
Published: (2022-12-01)